Immunological characterization of Mycoplasma hyopneumoniae recombinant proteins.

Authors:
Address: Núcleo de Biotecnologia, Centro de Desenvolvimento Tecnológico, Universidade Federal de Pelotas, Pelotas, RS, Brazil. simonesimionatto@ufgd.edu.br
Journal:


Publication:

abstract

Mycoplasma hyopneumoniae, the primary pathogen of enzootic pneumonia, is highly prevalent worldwide and causes major economic losses to the pig industry. Commercial vaccines are widely used in the control of this disease, however, they provide only partial protection. The aim of this study was to evaluate 34 recombinant proteins of M. hyopneumoniae expressed in Escherichia coli. Antigenic and immunogenic properties of these proteins were analyzed. For this, the proteins were tested against hyperimmune and convalescent pig sera through ELISA and Western blot. Immunogenicity of the recombinant proteins was evaluated in BALB/c mice following intramuscular inoculation. Most antigens were able to induce a strong immune response and sera from inoculated mice were able to recognize native proteins by cell ELISA and Western blot. Several recombinant proteins were specifically recognized by convalescent pig sera, indicating they are expressed during infection. These data may help to develop more efficacious vaccines against M. hyopneumoniae.

Copyright © 2012 Elsevier Ltd. All rights reserved.



Related Articles
Production and characterization of recombinant transmembrane proteins from Mycoplasma hyopneumoniae.
Vet Microbiol. 2012
Production and characterization of recombinant transmembrane proteins from Mycoplasma hyopneumoniae.
Marchioro SB, Simionatto S, Galli V, Conceição FR, Brum CB, Fisch A, Gomes CK, Dellagostin OA. Vet Microbiol. 2012 Feb 24; 155(1):44-52. Epub 2011 Aug 7.
Identification and immunological characterization of conserved Mycoplasma hyopneumoniae lipoproteins Mhp378 and Mhp651.
Vet Microbiol. 2006
Identification and immunological characterization of conserved Mycoplasma hyopneumoniae lipoproteins Mhp378 and Mhp651.
Meens J, Selke M, Gerlach GF. Vet Microbiol. 2006 Aug 25; 116(1-3):85-95. Epub 2006 May 2.
Immune responses induced by replication-defective adenovirus expressing the C-terminal portion of the Mycoplasma hyopneumoniae P97 adhesin.
Clin Vaccine Immunol. 2007
Immune responses induced by replication-defective adenovirus expressing the C-terminal portion of the Mycoplasma hyopneumoniae P97 adhesin.
Okamba FR, Moreau E, Cheikh Saad Bouh K, Gagnon CA, Massie B, Arella M. Clin Vaccine Immunol. 2007 Jun; 14(6):767-74. Epub 2007 Apr 4.
Review Control of Mycoplasma hyopneumoniae infections in pigs.
Vet Microbiol. 2008
Review Control of Mycoplasma hyopneumoniae infections in pigs.
Maes D, Segales J, Meyns T, Sibila M, Pieters M, Haesebrouck F. Vet Microbiol. 2008 Jan 25; 126(4):297-309. Epub 2007 Sep 22.
Review Mycoplasma hyopneumoniae: interaction with other agents in pigs, and evaluation of immunogens.
Arch Med Res. 1994
Review Mycoplasma hyopneumoniae: interaction with other agents in pigs, and evaluation of immunogens.
Ciprián A, Cruz TA, de la Garza M. Arch Med Res. 1994 Summer; 25(2):235-9.

To top Home


Show map | Diseases | Vaccination | Chronic disease | Medicine | Pregnancy | Heat & Sunburn | Cold | Security | Useful tips | Faq | News

TraveldoctorOnline 2001 • Disclaimer webmaster

The contents within traveldoctoronline are presented only for informational purposes and cannot substitute for professional health care or any other medical treatment.All users of this website with health problems should be oblige always to consult their medical doctor before starting any treatment.